Clinical characteristics and outcome of coronavirus disease 2019 infection in patients with solid organ transplants: A systematic review and meta-analysis
- PMID: 35193818
- PMCID: PMC8857642
- DOI: 10.1016/j.jiph.2022.02.002
Clinical characteristics and outcome of coronavirus disease 2019 infection in patients with solid organ transplants: A systematic review and meta-analysis
Abstract
Background: Although many studies have reported cases of COVID-19 infection in transplant recipients, most of them only involve a small number of patients and narrow geographic areas. This study aims to investigate the clinical characteristics, morbidity, severity, and mortality of COVID-19 infection among solid organ transplant (SOT) recipients by meta-analysis.
Method: We performed a literature search using the databases PubMed, Web of Science, and Google Scholar as of November 26, 2020. We included randomized controlled trials and cohort studies, excluding case reports and small case series (n < 10). The pooled incidence proportion and 95% confidence intervals (CI) were used to estimate the combined results of forty-seven studies were included for the meta-analysis. Heterogeneity was assessed using I2. Freeman-Tukey double arcsine transformation was used to stabilize the specific rate variance. Publication bias was using Egger's test.
Results: The morbidity rate of COVID-19 in SOT recipients was 2.10% [95% CI 1.35-3.01], and the proportion of severe infection was 22.46% [95% CI 15.74-29.90]. The mortality rate was 17.38% [95% CI 13.72-21.34]. In the analysis by transplanted organ, the proportion of patients with severe infection was highest in recipients of two or more transplants 48.85% [95% CI 11.88-86.38]. The mortality rate was highest in lung transplant recipients 25.12% [95% CI 16.94-34.00]. The most common symptoms of COVID-19 in SOT recipients were fever (73.39%), cough (58.90%), and respiratory symptoms (45.77%).
Conclusion: SOT was a risk factor for worse COVID-19 outcomes, although the morbidity of COVID-19 in SOT recipients was not markedly higher than the general population. These results may change when our understanding of the disease progress.
Keywords: COVID-19; Meta-analysis; SOT; Solid organ transplantation.
Copyright © 2022 The Author(s). Published by Elsevier Ltd.. All rights reserved.
Figures
Similar articles
-
The association between severe or death COVID-19 and solid organ transplantation: A systematic review and meta-analysis.Transplant Rev (Orlando). 2021 Jul;35(3):100628. doi: 10.1016/j.trre.2021.100628. Epub 2021 May 21. Transplant Rev (Orlando). 2021. PMID: 34087553 Free PMC article.
-
COVID-19 in solid organ transplant recipients: No difference in survival compared to general population.Transpl Infect Dis. 2021 Feb;23(1):e13421. doi: 10.1111/tid.13421. Epub 2020 Aug 2. Transpl Infect Dis. 2021. PMID: 32779808 Free PMC article.
-
A propensity score-matched analysis of mortality in solid organ transplant patients with COVID-19 compared to non-solid organ transplant patients.PLoS One. 2021 Mar 3;16(3):e0247251. doi: 10.1371/journal.pone.0247251. eCollection 2021. PLoS One. 2021. PMID: 33657157 Free PMC article.
-
An overview of COVID-19 in solid organ transplantation.Clin Microbiol Infect. 2022 Jun;28(6):779-784. doi: 10.1016/j.cmi.2022.02.005. Epub 2022 Feb 18. Clin Microbiol Infect. 2022. PMID: 35189336 Free PMC article. Review.
-
Is the Omicron variant truly less virulent in solid organ transplant recipients?Transpl Infect Dis. 2022 Dec;24(6):e13923. doi: 10.1111/tid.13923. Epub 2022 Aug 12. Transpl Infect Dis. 2022. PMID: 35915957 Free PMC article.
Cited by
-
Effect of COVID-19 on Kidney Graft Function One Year after Onset.Medicina (Kaunas). 2023 Dec 23;60(1):26. doi: 10.3390/medicina60010026. Medicina (Kaunas). 2023. PMID: 38256287 Free PMC article.
-
Immunogenicity of a Third Dose of BNT162b2 Vaccine among Lung Transplant Recipients-A Prospective Cohort Study.Vaccines (Basel). 2023 Apr 4;11(4):799. doi: 10.3390/vaccines11040799. Vaccines (Basel). 2023. PMID: 37112711 Free PMC article.
-
A review of the clinical characteristics and management of immunosuppressed patients living with HIV or solid organ transplants infected with SARS-CoV-2 omicron variants.Front Public Health. 2024 Feb 22;12:1327093. doi: 10.3389/fpubh.2024.1327093. eCollection 2024. Front Public Health. 2024. PMID: 38454994 Free PMC article. Review.
-
CT imaging findings in lung transplant recipients with COVID-19.Eur Radiol. 2023 Mar;33(3):2089-2095. doi: 10.1007/s00330-022-09148-w. Epub 2022 Sep 24. Eur Radiol. 2023. PMID: 36152040 Free PMC article.
-
Viral rebound and safety of nirmatrelvir/ritonavir for lung-transplant recipients infected with SARS-CoV-2.Biosaf Health. 2023 Sep 2;5(5):266-271. doi: 10.1016/j.bsheal.2023.08.004. eCollection 2023 Oct. Biosaf Health. 2023. PMID: 40078909 Free PMC article.
References
-
- 〈https://covid19.who.int/?gclid=CjwKCAiA8Jf-BRB-EiwAWDtEGtGy30myGkh6lL-P... (accessed December 1, 2020).
-
- 〈https://covid.cdc.gov/covid-data-tracker〉 (Accessed Dec 1, 2020).
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical